August 2009

New drug targeted for Kaposi’s sarcoma

Tue Aug 18, 2009

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease. This research was published online in Nature Chemical Biology, July 26, 2009. The lead author is Tina Shahian, UCSF Graduate Group in Biochemistry and Molecular Biology.

Update from the Dean - Spring/Summer 2009

Mon Aug 3, 2009

New chancellor: Desmond-Hellman; budget update: 4% to 10% salary cuts via furloughs, possibly to be renewed; risk of poison control system closure; new Department of Bioengineering and Therapeutic Sciences; faculty honors and awards: Burchard, Peck, Desai, Roy, Bero, MacDougall, Hessol, Phillips, Tsourounis, Apollonio, Wells, Fujimori. Appointments: Babbitt, Sali, Wells, Benowitz.